[
    [
        {
            "time": "2023-10-10",
            "original_text": "沃森生物：合作研发的新型冠状病毒mRNA疫苗处于一期临床试验阶段",
            "features": {
                "keywords": [
                    "沃森生物",
                    "mRNA疫苗",
                    "新型冠状病毒",
                    "一期临床试验"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：合作研发的新型冠状病毒mRNA疫苗处于一期临床试验阶段",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "沃森生物：新冠病毒mRNA疫苗临床试验相关工作在正常开展中",
            "features": {
                "keywords": [
                    "沃森生物",
                    "mRNA疫苗",
                    "新冠病毒",
                    "临床试验",
                    "正常开展"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：新冠病毒mRNA疫苗临床试验相关工作在正常开展中",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "沃森生物：合作研发的新型冠状病毒疫苗处于一期临床试验阶段",
            "features": {
                "keywords": [
                    "沃森生物",
                    "新型冠状病毒疫苗",
                    "一期临床试验"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：合作研发的新型冠状病毒疫苗处于一期临床试验阶段",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        }
    ]
]